Wellgistics Health Inc (WGRX)
NASDAQ:WGRX
Want to see WGRX full AI Analyst Report?
WGRX Stock Chart & Stats
$0.14
--
Market closed
$0.14
--
Day’s Range― - ―
52-Week Range$3.04 - $97.50
Previous CloseN/A
VolumeN/A
Average Volume (3M)28.82M
Market Cap
$5.70M
Enterprise Value$37.28M
Total Cash (Recent Filing)$51.73K
Total Debt (Recent Filing)$28.73M
Price to Earnings (P/E)―
Beta0.68
Next EarningsN/A
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)N/A
Shares Outstanding2,513,425
10 Day Avg. Volume1,367,507
30 Day Avg. Volume28,820,997
Financial Highlights & Ratios
PEG Ratio>-0.01
Price to Book (P/B)-2.28
Price to Sales (P/S)1.22
P/FCF Ratio-2.61
Enterprise Value/Market Cap6.54
Enterprise Value/Revenue2.66
Enterprise Value/Gross Profit-3.54
Enterprise Value/Ebitda-0.70
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Bulls Say, Bears Say
Bulls Say
Integrated AI + Blockchain PlatformWellgistics is pursuing an integrated AI and blockchain stack (EinsteinRx, PharmacyChain) plus patents (QOLPOM) to own data, verification and patient relationships. That vertical strategy can create durable platform advantages, proprietary data flywheels and differentiated services for pharmacies and payors.
Joint Venture Expands Patient ReachThe Healthstar JV creates a majority-owned distribution and telepharmacy hub integrating EinsteinRx and HubRx, accelerating direct-to-patient channels. Ownership plus shared IP and access to ~200k patient lives supports recurring revenue growth, network effects, and durable commercial scale if integrated effectively.
Completed Material Financing To Extend RunwayThe sizable private convertible financing materially bolstered near-term liquidity and enabled partial debt repayment. This extends runway to execute strategic transactions and integrations, reducing immediate solvency pressure and giving management time to stabilize operations and pursue value-creating partnerships.
Bears Say
Sharp Revenue And Margin DeteriorationSteep revenue declines paired with deeply negative gross and net margins indicate structural problems with pricing, cost of goods sold or product mix. Such deterioration undermines operating leverage, requires significant remediation to restore profitability, and makes scaling the platform economically challenging.
Negative Equity And Elevated LeverageNegative shareholders' equity and significant debt materially constrain financial flexibility, complicate refinancing and raise solvency risk. A weakened capital structure limits strategic options, increases creditor oversight, and could trigger listing or covenant issues absent successful recapitalization or profitable operations.
Persistent Cash BurnSustained negative operating and free cash flow means the business remains reliant on external financing to fund operations. Even with modest FCF improvement, ongoing cash burn increases dilution and refinancing risk, limiting the company's ability to invest organically in product development and commercialization long-term.
Wellgistics Health Inc News
WGRX FAQ
What was Wellgistics Health Inc’s price range in the past 12 months?
Wellgistics Health Inc lowest stock price was $3.04 and its highest was $97.50 in the past 12 months.
What is Wellgistics Health Inc’s market cap?
Wellgistics Health Inc’s market cap is $5.70M.
When is Wellgistics Health Inc’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were Wellgistics Health Inc’s earnings last quarter?
Currently, no data Available
Is Wellgistics Health Inc overvalued?
According to Wall Street analysts Wellgistics Health Inc’s price is currently Overvalued.
Does Wellgistics Health Inc pay dividends?
Wellgistics Health Inc does not currently pay dividends.
What is Wellgistics Health Inc’s EPS estimate?
Wellgistics Health Inc’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Wellgistics Health Inc have?
Wellgistics Health Inc has 2,513,425 shares outstanding.
What happened to Wellgistics Health Inc’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Wellgistics Health Inc?
Currently, no hedge funds are holding shares in WGRX
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Wellgistics Health Inc
Wellgistics Health, Inc. functions as a primary wholesaler and distributor of pharmaceutical products throughout the United States, catering to both drug manufacturers and independent retail pharmacies. Its extensive product catalog includes a variety of generic and brand-name pharmaceuticals, alongside over-the-counter healthcare and consumer merchandise. The company also delivers a suite of third-party logistics (3PL) services, encompassing warehousing, inventory control, pick-and-pack operations, and shipping solutions, specifically designed for small to mid-sized pharmaceutical producers. Furthermore, Wellgistics manages the DelivMeds platform, an integrated pharmaceutical hub that streamlines prescription transfers and offers essential backend clinical concierge support to its network of independent pharmacies. It also runs a specialized retail community service. Established in 2022 and headquartered in Tampa, Florida, the organization adopted its current name, Wellgistics Health, Inc., in October 2024, having previously operated as Danam Health, Inc.
Technical Analysis
―
Prestige Consumer Healthcare
―
―
Synergy CHC
―
Guardian Pharmacy Services, Inc. Class A
―
Ownership Overview
13.69% Insiders
0.78% Mutual Funds
― Other Institutional Investors
85.09% Public Companies and
Individual Investors
Options Prices
Currently, No data available
---